Stemline Therapeutics (STML)

[cashcow3]

Perceptive Advisors LLC bought a new position in shares of Stemline Therapeutics during the fourth quarter worth $115,000. Bogle Investment Management L P DE bought a new position in shares of Stemline Therapeutics during the fourth quarter worth $1,015,000. Renaissance Technologies LLC raised its position in shares of Stemline Therapeutics by 7.9% in the fourth quarter. Renaissance Technologies LLC now owns 65,500 shares of the biopharmaceutical company’s stock worth $701,000 after buying an additional 4,800 shares during the period. Finally, J. Goldman & Co LP bought a new position in shares of Stemline Therapeutics during the fourth quarter worth $2,139,000. Institutional investors own 37.76% of the company’s stock.